Peter N. Buhre

Proton pump inhibitors and the risk of overanticoagulation during acenocoumarol maintenance treatment

Martina Teichert, Charlotte van Noord, André G. Uitterlinden et al. · British Journal of Haematology · 2011 · 46 citations · Full text

Hypertension, Heart Failure, Andersen-gill Extension +23

Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes

Martina Teichert, Mark Eijgelsheim, André G. Uitterlinden et al. · Pharmacogenetics and Genomics · 2010 · 44 citations

Agreement between Coaguchek XS and STA-R Evolution (Hepato Quick) INR results depends on the level of INR

Joseph S. Biedermann, Frank W.G. Leebeek, Peter N. Buhre et al. · Thrombosis Research · 2015 · 21 citations

Evolutionary Biology, Biostatistics, Coaguchek Xs +2

Validation of the Acenocoumarol EU-PACT Algorithms: Similar Performance in the Rotterdam Study Cohort as in the Original Study

Rianne MF van Schie, Nadia el Khedr, Talitha I. Verhoef et al. · Pharmacogenomics · 2012 · 14 citations · Full text

Impact of point‐of‐care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non‐self‐monitoring patients: a cohort study

Joseph S. Biedermann, Nienke van Rein, A M H P van den Besselaar et al. · Journal of Thrombosis and Haemostasis · 2016 · 10 citations

Vitamin K Antagonists, Therapeutic Drug Monitoring, Patient Safety +7